Riskpilot← Back to searchSign inGet full accessMEDEVICE AS
ASActiveOrg 919611227Brattbakken 18, 3772 KragerøEngineering activities and related technical consultancy · NACE 7112Est. 20171 employees
Revenue 2024
NOK 0
EBITDA margin
—
-273% vs 2023
Equity ratio
-81.1%
Financial strength
Net profit 2024
NOK -435K
-49% vs 2023
| Revenue | NOK 0 | — |
| EBITDA | NOK -190K | -273% |
| Net profit | NOK -435K | -49% |
| Total assets | NOK 632K | -23% |
| Equity | NOK -513K | -558% |
| Employees | 1 | — |
Legal name
MEDEVICE AS
Org number
919611227
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
4. oktober 2017
Share capital
NOK 37 500
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Selskapets formål er selv og gjennom andre selskaper å drive utvikling, produksjon og salg av produkter i plast og relatert virksomhet.
Address
Brattbakken 18, 3772 Kragerø
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 350 | 264 | 194 | 55 | 55 | 75 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −68 | −0 |
| EBITDA | −9 | −427 | 231 | 197 | 25 | −224 | −51 | −190 |
| Depreciation & amort. | −0 | −0 | −24 | −92 | −139 | −156 | −232 | −246 |
| EBIT | −9 | −427 | 207 | 105 | −114 | −380 | −283 | −436 |
| Net financials | 0 | 0 | 1 | 1 | 0 | 0 | −9 | 1 |
| Profit before tax | −9 | −426 | 208 | 106 | −114 | −380 | −292 | −435 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −9 | −426 | 208 | 106 | −114 | −380 | −292 | −435 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 421 | 395 | 602 | 713 | 639 | 433 | 817 | 632 |
| Equity | 421 | 395 | 602 | 708 | 594 | 214 | −78 | −513 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 5 | 45 | 219 | 895 | 1 145 |
| Total debt | 0 | 0 | 0 | 5 | 45 | 219 | 895 | 1 145 |
EBITDA margin
-18993600.0%
This company
15.8%
Market median
-120212758% vs market
20172024
Equity ratio
-81.1%
This company
38.2%
Market median
-312% vs market
20172024
Return on equity
-43472200.0%
This company
18.4%
Market median
-236262057% vs market
20172024
Net profit margin
-43472200.0%
This company
8.1%
Market median
-536693927% vs market
20172024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172024
Debt / equity
2.23×
This company
0.62×
Market median
-260% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-09-05 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JS Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
DN Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2024 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
S&S Norge As | Company | 20.0% | 20.0% | 2022 |
Eufori As | Company | 20.0% | 20.0% | 2022 |
Pynt As | Company | 20.0% | 20.0% | 2022 |
| Individual | 20.0% | 20.0% | 2022 | |
Et Innovasjon As | Company | 20.0% | 20.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MEDEVICE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Juliana Sarah Mansfield | Chief Executive Officer | 0 companies |
| Dag Nord | Chief Executive Officer | 0 companies |
| Preben René Hjallum | Chairman | 0 companies |
| Stephan Andreas Brackmann | Board of Directors | 0 companies |
| Arne Gustav Røseth | Board of Directors | 0 companies |